Pliant TherapeuticsÂ Inc (PLRX) Financials

$1.14

$-0.03 (-2.16%)

As on 08-Sep-2026 16:00EDT

Market cap

$72 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	1.58	9.69	7.57
Cost of Revenue	0.63	1.70	2.13	1.84	3.68	3.20
Gross Profit	-0.63	-1.70	-2.13	1.58	9.69	7.57
Operating Expenses	97.22	148.38	228.37	185.73	136.89	27.56
Operating Profit (EBIT)	-97.48	-150.07	-228.37	-184.15	-127.20	-19.99
Other Income	--	--	--	--	3.88	0.27
Profit before Tax	-92.29	-149.34	-210.30	-161.34	-123.32	-19.71
Provision for Tax	--	--	--	1.67	-1.82	-1.81
Profit after Tax (Net Income)	-92.29	-149.34	-210.30	-161.34	-123.32	-17.91
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-123.32	-19.71

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	146.93	181.21	304.08	473.58	313.34	199.06
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	26.47	27.66	59.65	10.05	13.36	5.33
Current Liabilities	16.48	16.37	33.22	28.52	23.91	16.83
Total Liabilities	206.37	225.23	396.95	512.15	350.61	221.22

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	26.74	28.78	34.69	6.65	10.30	11.77
Current Assets	163.14	196.45	362.26	505.50	340.31	209.44
Total Assets	206.37	225.23	396.95	512.15	350.61	221.22
Total Debt*	28.74	29.11	60.19	11.37	15.82	7.19
Net Current Assets	146.66	180.08	329.05	476.98	316.40	192.61

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-128.34	-155.50	-116.36	-94.63	-75.44
Cash Flow from Investing Activities	--	134.29	140.34	-127.01	-150.20	73.70
Cash from Financing Activities	--	-31.70	23.12	274.41	226.85	2.53
Net Cash Inflow / Outflow	--	--	--	--	-17.98	0.78

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.50	-2.43	-3.47	-2.69	-2.53	-0.50
Cash EPS ($)	--	-2.41	-3.44	-2.66	-2.49	-0.45
Adjusted Book Value ($)	--	2.95	5.02	7.91	6.42	5.53
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.09	-2.57	-1.94	-1.94	-2.09
Free Cash Flow per Share ($)	--	-2.10	-2.63	-1.96	-1.98	-2.15

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-51.98	-49.53	-39.64	-46.07	-7.31
ROE (%)	-56.25	-61.55	-54.09	-41.00	-48.13	-7.43
ROA (%)	-35.04	-48.01	-46.27	-37.40	-43.13	-6.93
EBIT Margin (%)	--	--	--	-10,130.95	-1,265.15	-263.95
Net Margin (%)	--	--	--	-10,211.14	-909.18	-228.29
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	-1.00	-0.84	0.28	-0.82
EBIT Growth (%)	56.11	29.19	-29.49	-30.64	-513.08	52.01
Net Profit Growth (%)	55.41	28.99	-30.35	-30.83	-588.67	54.95
EPS Growth (%)	55.88	0.30	-0.29	-0.07	-4.09	0.56
Book Value Growth (%)	-33.81	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.50	-3.79	-6.72	-7.65	-27.16
Price / Book Value	0.48	0.41	2.62	2.29	3.01	2.44
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.54	0.60	-2.45	-3.80	-5.28	-15.87
Close Price ($)	1.14	1.22	13.17	18.11	19.33	13.50
High Price ($)	1.95	13.71	19.62	36.64	26.25	43.92
Low Price ($)	1.09	1.10	10.22	12.61	3.97	11.91
Market Cap ($ Cr)	71.83	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.16	0.20	0.02	0.05	0.04
Short term debt to equity ratio	0.02	0.01	0.00	0.00	0.01	0.01
Current Ratio	9.90	12.00	10.91	17.72	14.23	12.44
Quick Ratio	9.90	--	--	--	14.23	12.44
Interest Coverage	-33.40	-57.36	-68.54	-126.34	-154.91	-73.48

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	189.68	32.46	32.57
Asset Turnover	--	--	--	0.00	0.03	0.03
Receivable days	--	--	--	709.81	105.78	285.27
Inventory Days	--	--	--	0.00	0.00	0.00
Payable days	--	693.46	901.61	606.20	225.79	284.65
Cash Conversion Cycle	--	--	--	103.61	-120.00	0.62

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.